This grant seeks funds to continue the work of the Statistical Unit for the Radiation Therapy Oncology Group (RTOG) within the American College of Radiology located in Philadelphia, Pennsylvania. The Statistical Unit provides support for all RTOG related activities such as: -the statistical analyses needed for the development of new protocols -the preparation of data collection forms and coding schemes -the analyses of data for existing protocols and the generation of interim reports -the preparation of final reports which serve as the basis for publications In addition, the Statistical Unit plans to establish cross-protocol data bases to study the following: -late effects for conventional and unconventional franctionation schemes in four disease sites (lung, head & neck, brain and bladder) -conventional treatment baselines for four disease sites (lung, head & neck, brain and bladder) -cross-protocol treatment comparisons (i.e. an overview/comparison of all misonidazole studies) -site specific treatment overviews (i.e. an overview/comparison of all head and neck studies for a specific site such as oral cavity) Emphasis will be placed on the preparation of manuscripts for both medical and statistical journals. The RTOG maintains a commitment to the interaction of clinicians and statisticians in the development of contributions to the scientific literature.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA032115-05
Application #
3557256
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1982-04-15
Project End
1989-03-31
Budget Start
1986-04-01
Budget End
1987-03-31
Support Year
5
Fiscal Year
1986
Total Cost
Indirect Cost
Name
American College of Radiology
Department
Type
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Li, Donghui; Moughan, Jennifer; Crane, Christopher et al. (2016) RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncology Group 9704. Int J Radiat Oncol Biol Phys 94:554-60
Hamstra, Daniel A; Bae, Kyounghwa; Hanks, Gerald et al. (2015) Impact of biochemical failure classification on clinical outcome: a secondary analysis of Radiation Therapy Oncology Group 9202 and 9413. Cancer 121:844-52
Ben-Josef, Edgar; George, Asha; Regine, William F et al. (2015) Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas. Clin Cancer Res 21:5612-8
Xiao, Canhua; Hanlon, Alexandra; Zhang, Qiang et al. (2014) Risk factors for clinician-reported symptom clusters in patients with advanced head and neck cancer in a phase 3 randomized clinical trial: RTOG 0129. Cancer 120:848-54
Cairncross, J Gregory; Wang, Meihua; Jenkins, Robert B et al. (2014) Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH. J Clin Oncol 32:783-90
Komaki, Ritsuko; Paulus, Rebecca; Blumenschein Jr, George R et al. (2014) EGFR expression and survival in patients given cetuximab and chemoradiation for stage III non-small cell lung cancer: a secondary analysis of RTOG 0324. Radiother Oncol 112:30-6
Hsu, I-Chow; Hunt, Daniel; Straube, William et al. (2014) Dosimetric analysis of radiation therapy oncology group 0321: the importance of urethral dose. Pract Radiat Oncol 4:27-34
Xiao, Canhua; Hanlon, Alexandra; Zhang, Qiang et al. (2013) Symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy. Oral Oncol 49:360-6
Cairncross, Gregory; Wang, Meihua; Shaw, Edward et al. (2013) Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol 31:337-43
Lawrence, Yaacov Richard; Paulus, Rebecca; Langer, Corey et al. (2013) The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801. Lung Cancer 80:298-305

Showing the most recent 10 out of 274 publications